Mount Sinai Hospital Cardiothoracic Surgery 1190 5 Ave #1028, New York, NY 10029 2126596800 (phone), 2126596818 (fax)
Kings County Hospital Center Surgery 451 Clarkson Ave FL 4, Brooklyn, NY 11203 7182454146 (phone), 7182453011 (fax)
Education:
Medical School Madras Med Coll, Dr M G R Med Univ, Madras, Tn, India Graduated: 1985
Procedures:
Coronary Artery Bypass Heart Valve Procedures Hernia Repair Pacemaker and Defibrillator Procedures Removal Procedures on the Lungs and Pleura Septal Defect Repair Thoracic Aortic Aneurysm Repair Thoracoscopy Tracheostomy Upper Gastrointestinal Endoscopy
Conditions:
Abdominal Hernia Aortic Aneurism Congenital Anomalies of the Heart Gastric Cancer Lung Cancer
Languages:
English French Italian Spanish Vietnamese
Description:
Dr. Reddy graduated from the Madras Med Coll, Dr M G R Med Univ, Madras, Tn, India in 1985. He works in Brooklyn, NY and 1 other location and specializes in Congenital Cardiac Surgery (Thoracic Surgery). Dr. Reddy is affiliated with Kings County Hospital Center.
Arjula Ramachandra Reddy is a distinguished biologist whose research work in the field of Genetics and Plant Biotechnology is recognized worldwide. ...
Ramachandra Reddy - Houston TX, US Parkash Gill - Los Angeles CA, US
Assignee:
VasGene Therapeutics, Inc. - Los Angeles CA
International Classification:
C07H 21/04
US Classification:
536 245, 536 2431, 435 6, 435325, 435375, 514 44
Abstract:
In certain embodiments, this present disclosure provides nucleic acid compounds, compositions, and methods for inhibiting Ephrin B2 or EphB4 expression. In certain embodiments, the present disclosure provides methods and compositions for treating cancer or for treating angiogenesis-associated diseases.
Polypeptide Compounds For Inhibiting Angiogenesis And Tumor Growth
Valery Krasnoperov - South Pasadena CA, US Nathalie Kertesz - Calabasas CA, US Ramachandra Reddy - Los Angeles CA, US Parkash Gill - Los Angeles CA, US Sergey Zozulya - San Diego CA, US
Assignee:
Vasgene Therapeutics, Inc. - Los Angeles CA
International Classification:
A61K 39/395
US Classification:
4241411
Abstract:
In certain embodiments, this present invention provides polypeptide compositions, and methods for inhibiting Ephrin B2 or EphB4 activity. In other embodiments, the present invention provides methods and compositions for treating cancer or for treating angiogenesis-associated diseases.
Polypeptide Compounds For Inhibiting Angiogenesis And Tumor Growth
Valery Krasnoperov - South Pasadena CA, US Nathalie Kertesz - Agoura Hills CA, US Ramachandra Reddy - Conshohocken PA, US Parkash Gill - Agoura Hills CA, US Sergey Zozulya - San Diego CA, US
Assignee:
VasGene Therapeutics, Inc. - Agoura Hills CA
International Classification:
C07K 16/00
US Classification:
5303881
Abstract:
In certain embodiments, this present invention provides polypeptide compositions (e. g. , antibodies and antigen binding portions thereof that bind to EphB4), and methods for inhibiting EphB4 activity. In other embodiments, the present invention provides methods and compositions for treating cancer or for treating angiogenesis-associated diseases.
Polypeptide Compounds For Inhibiting Angiogenesis And Tumor Growth
Valery Krasnoperov - South Pasadena CA, US Nathalie Kertesz - Agoura Hills CA, US Ramachandra Reddy - Pearland TX, US Parkash Gill - Agoura Hills CA, US Sergey Zozulya - San Diego CA, US
Assignee:
VasGene Therapeutics, Inc. - Agoura Hills CA
International Classification:
C07K 1/00 A61K 39/00
US Classification:
530350, 4241841
Abstract:
In certain embodiments, this present invention provides polypeptide compositions, and methods for inhibiting Ephrin B2 or EphB4 activity. In other embodiments, the present invention provides methods and compositions for treating cancer or for treating angiogenesis-associated diseases.
Polypeptide Compounds For Inhibiting Angiogenesis And Tumor Growth
Valery Krasnoperov - South Pasadena CA, US Nathalie Kertesz - Agoura Hills CA, US Ramachandra Reddy - Conshohocken PA, US Parkash Gill - Agoura Hills CA, US Sergey Zozulya - San Diego CA, US
Assignee:
VasGene Therapeutics, Inc. - Agoura Hills CA
International Classification:
C07K 16/00
US Classification:
5303881
Abstract:
In certain embodiments, this present invention provides polypeptide compositions, and methods for inhibiting Ephrin B2 or EphB4 activity. In other embodiments, the present invention provides methods and compositions for treating cancer or for treating angiogenesis-associated diseases.
Polypeptide Compounds For Inhibiting Angiogenesis And Tumor Growth
Valery Krasnoperov - South Pasadena CA, US Sergey Zozulya - San Diego CA, US Nathalie Kertesz - Calabasas CA, US Ramachandra Reddy - Pearland TX, US Parkash Gill - Agoura Hills CA, US
In certain embodiments, this present invention provides polypeptide compositions, and methods for inhibiting Ephrin B2 or EphB4 activity. In other embodiments, the present invention provides methods and compositions for treating cancer or for treating angiogenesis-associated diseases.
Compositions And Methods For Detecting And Treating Tumors
Ramachandra Reddy - Pearland TX, US Parkash Gill - Agoura Hills CA, US
Assignee:
VasGene Therapeutics, Inc. - Sharon Hills PA
International Classification:
C12Q 1/68
US Classification:
435006000
Abstract:
In certain embodiments, this present disclosure provides compositions and methods for detecting EphB4 gene amplification in test cells. In certain embodiments, the present disclosure provides methods and compositions for evaluating tumor (cancer) status and prognosis in a subject having or suspected of having a tumor.
Polypeptide Compounds For Inhibiting Angiogenesis And Tumor Growth
Valery Krasnoperov - South Pasadena CA, US Nathalie Kertesz - Agoura CA, US Ramachandra Reddy - Pearland TX, US Parkash Gill - Agoura Hills CA, US Sergey Zozulya - San Diego CA, US
In certain embodiments, this present invention provides polypeptide compositions, including compositions containing a modified polypeptide, and methods for inhibiting Ephrin B2 or EphB4 activity. In other embodiments, the present invention provides methods and compositions for treating cancer or for treating angiogenesis-associated diseases.